GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $992,000 | -84.6% | 23,010 | -84.5% | 0.01% | -83.3% |
| Q2 2016 | $6,438,000 | -11.2% | 148,560 | -16.9% | 0.04% | -32.1% |
| Q1 2016 | $7,250,000 | +2.9% | 178,760 | +2.3% | 0.05% | -1.9% |
| Q4 2015 | $7,047,000 | -9.9% | 174,660 | -14.2% | 0.05% | -16.9% |
| Q3 2015 | $7,823,000 | +455.2% | 203,460 | +501.3% | 0.06% | +622.2% |
| Q2 2015 | $1,409,000 | -8.8% | 33,835 | +1.1% | 0.01% | -25.0% |
| Q1 2015 | $1,545,000 | +25.3% | 33,475 | +16.1% | 0.01% | +33.3% |
| Q4 2014 | $1,233,000 | -79.1% | 28,840 | -77.5% | 0.01% | -79.5% |
| Q3 2014 | $5,895,000 | -34.2% | 128,225 | -23.5% | 0.04% | -4.3% |
| Q2 2014 | $8,965,000 | -3.6% | 167,640 | -3.6% | 0.05% | -34.3% |
| Q1 2014 | $9,296,000 | -12.4% | 173,985 | -12.5% | 0.07% | -20.5% |
| Q4 2013 | $10,611,000 | +65.8% | 198,740 | +55.5% | 0.09% | +158.8% |
| Q3 2013 | $6,399,000 | +101.4% | 127,800 | +100.9% | 0.03% | 0.0% |
| Q2 2013 | $3,178,000 | – | 63,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |